1. Home
  2. NSP vs AGMB Comparison

NSP vs AGMB Comparison

Compare NSP & AGMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Insperity Inc.

NSP

Insperity Inc.

HOLD

Current Price

$31.73

Market Cap

819.5M

ML Signal

HOLD

AGMB

AgomAb Therapeutics NV American Depositary Shares

N/A

Current Price

$10.71

Market Cap

677.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NSP
AGMB
Founded
1986
2017
Country
United States
Belgium
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
819.5M
677.9M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
NSP
AGMB
Price
$31.73
$10.71
Analyst Decision
Hold
Buy
Analyst Count
3
3
Target Price
$47.67
$32.00
AVG Volume (30 Days)
816.6K
182.7K
Earning Date
04-30-2026
06-16-2026
Dividend Yield
8.30%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,812,000,000.00
N/A
Revenue This Year
$3.45
N/A
Revenue Next Year
$6.95
$33.33
P/E Ratio
N/A
N/A
Revenue Growth
3.51
N/A
52 Week Low
$18.57
$9.00
52 Week High
$80.45
$17.45

Technical Indicators

Market Signals
Indicator
NSP
AGMB
Relative Strength Index (RSI) 67.21 42.95
Support Level $31.00 $9.82
Resistance Level $39.86 $12.06
Average True Range (ATR) 1.75 1.23
MACD 0.47 0.17
Stochastic Oscillator 96.55 56.21

Price Performance

Historical Comparison
NSP
AGMB

About NSP Insperity Inc.

Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.

About AGMB AgomAb Therapeutics NV American Depositary Shares

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.

Share on Social Networks: